This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mitoimmune Therapeutics Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Soon Ha Kim: Pharmaceutical Crystalline-Form Inventor
Introduction
Soon Ha Kim is an inventor based in Seoul, South Korea. His patent work concerns the crystalline form of a pharmaceutical compound and its physical and chemical stability. The available information identifies 1 patent associated with him.
Latest Patents
Kim’s listed patent is titled “Crystalline Forms of 5-[(1,1-dioxido-4-thiomorpholinyl)methyl]-2-phenyl-N-(tetrahydro-2H-pyran-4-yl)-1H-indol-7-amine.” It describes Crystalline Form A of the compound and reports advantages over amorphous and other crystalline forms, including resistance to denaturation under prolonged harsh conditions, low water sorption, and stability during pressure and pulverization. These properties are presented as beneficial for formulation and extended storage.
Career Highlights
The supplied information associates Kim with Mitoimmune Therapeutics Inc. His listed patent highlights work on improving the stability and handling characteristics of a pharmaceutical compound in crystalline form.
Collaborations
Hye Kyung Chang and Hyoung Jin Kim are identified as Kim’s coworkers. The available details do not specify their roles in the patent or their particular contributions.
Conclusion
Soon Ha Kim’s listed invention focuses on a stable crystalline form designed to support pharmaceutical formulation and long-term storage.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile